Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cellgram-CKD
- Development stage
- Phase 1
- Lead developer
- Pharmicell
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous
01
Overview
Cellgram-CKD is an allogeneic bone marrow-derived mesenchymal stem cell therapy developed for the treatment of chronic kidney disease (CKD). The product consists of mesenchymal stem cells sourced from donor bone marrow and is administered intravenously. Its mechanism of action involves apoptosis inhibition and cellular replacement, aiming to slow or reverse kidney damage by inhibiting cell death and promoting tissue regeneration in the kidneys. Developed by Pharmicell, Cellgram-CKD has been evaluated in phase 1 clinical trials for safety in patients with CKD. The drug represents a novel approach within regenerative medicine, targeting urogenital diseases with a focus on chronic kidney disease[1][6].
- Brand names
- Cellgram-CKD
- Other names
- Allogeneic bone marrow-derived mesenchymal stem cell therapy
Beyond the preview
Go deeper on Cellgram-CKD.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cellgram-CKD.